B
UTHR icon

BancorpSouth’s United Therapeutics UTHR Stock Holding History

BancorpSouth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$348K Buy
2,968
+86
+3% +$11K 0.03% 178
2017
Q2 		$374K Buy
2,882
+324
+13% +$40.4K 0.04% 151
2017
Q1 		$346K Buy
2,558
+664
+35% +$101K 0.04% 151
2016
Q4 		$272K Hold
1,894
– – 0.03% 171
2016
Q3 		$224K Buy
+1,894
New +$228K 0.02% 211

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BancorpSouth's UTHR Position: Q3 2017 in Review

BancorpSouth increased its United Therapeutics (UTHR) stake by 3% in Q3 2017, buying an estimated $11K and bringing the position to 2,968 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #178.

BancorpSouth first reported a position in UTHR in Q3 2016 and has held it in 5 quarters since. The position peaked at $374K in Q2 2017. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2017.

  • BancorpSouth held 2,968 shares of United Therapeutics worth $348K as of Q3 2017.
  • BancorpSouth bought 86 United Therapeutics shares in Q3 2017, an estimated $11K.
  • United Therapeutics made up 0.03% of BancorpSouth's portfolio in Q3 2017, its #178 holding.
  • BancorpSouth first reported a position in United Therapeutics in Q3 2016 and has held it in 5 quarters since.
  • BancorpSouth's United Therapeutics position peaked at $374K in Q2 2017.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.